Counteracting Interleukin-15 to Elucidate Its Modes of Action in Physiology and Pathology
- 1 January 2023
- journal article
- review article
- Published by Mary Ann Liebert Inc in Journal of Interferon & Cytokine Research
- Vol. 43 (1), 2-22
- https://doi.org/10.1089/jir.2022.0198
Abstract
Interleukin (IL)-15 belongs to the common gamma-dependent cytokine family, along with IL-2, IL-4, IL-7, IL-9, and IL-21. IL-15 is crucial for the homeostasis of Natural Killer (NK) and memory CD8 T cells, and to fight against cancer progression. However, dysregulations of IL-15 expression could occur and participate in the emergence of autoimmune inflammatory diseases as well as hematological malignancies. It is therefore important to understand the different modes of action of IL-15 to decrease its harmful action in pathology without affecting its beneficial effects in the immune system. In this review, we present the different approaches used by researchers to inhibit the action of IL-15, from most broad to the most selective. Indeed, it appears that it is important to selectively target the mode of action of the cytokine rather than the cytokine itself as they are involved in numerous biological processes.Keywords
This publication has 173 references indexed in Scilit:
- Aberrant Overexpression of IL-15 Initiates Large Granular Lymphocyte Leukemia through Chromosomal Instability and DNA HypermethylationCancer Cell, 2012
- Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15Nature Immunology, 2012
- Ectodomain Shedding of Interleukin-2 Receptor β and Generation of an Intracellular Functional FragmentOnline Journal of Public Health Informatics, 2010
- Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytesProceedings of the National Academy of Sciences of the United States of America, 2009
- New insights into the regulation of T cells by γc family cytokinesNature Reviews Immunology, 2009
- Network model of survival signaling in large granular lymphocyte leukemiaProceedings of the National Academy of Sciences of the United States of America, 2008
- Membrane bound IL-15 is increased on CD14 monocytes in early stages of MSJournal of Neuroimmunology, 2008
- Modification of adverse inflammation is required to cure new-onset type 1 diabetic hostsProceedings of the National Academy of Sciences of the United States of America, 2007
- The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine designNature Reviews Immunology, 2006
- Converting IL-15 to a superagonist by binding to soluble IL-15RαProceedings of the National Academy of Sciences of the United States of America, 2006